Inabata & Co Ltd (8098):企業の財務・戦略的SWOT分析

◆英語タイトル:Inabata & Co Ltd (8098) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C8974
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:化学
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Inabata & Co Ltd (8098) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Inabata & Co Ltd (Inabata) is a trading company that trades plastics, chemicals, IT-related products, fruit juice and frozen vegetables. The company owns and operates manufacturing and processing base for compounding, molding and processing of resins and rubber. The company also has manufacturing units for processing of coating materials, plastic films, fine chemicals and processing of grip tape for sports industry. It procures and sells plastics for automotive, home appliances, office automation, packaging material and beverages industries. The company also markets resin materials to resin manufacturer and rubber materials to automotive industry. The company has operations in Asia Pacific, North America, South America and Europe. Inabata is headquartered in Chuo-ku, Osaka, Japan.

Inabata & Co Ltd Key Recent Developments

Dec 22,2017: Shanghai Inabata Trading Hefei office moves to Anhui Province

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Inabata & Co Ltd – Key Facts 6
Inabata & Co Ltd – Key Employees 7
Inabata & Co Ltd – Major Products and Services 9
Inabata & Co Ltd – History 10
Inabata & Co Ltd – Company Statement 13
Inabata & Co Ltd – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 17
Company Overview 17
Inabata & Co Ltd – Business Description 18
Business Segment: Chemicals 18
Overview 18
Performance 18
Business Segment: Housing and Eco Materials 18
Overview 18
Performance 18
Business Segment: IT and Electronics 18
Overview 18
Performance 19
Business Segment: Life Industry 19
Overview 19
Performance 19
Business Segment: Others 19
Overview 19
Performance 19
Business Segment: Plastics 19
Overview 19
Performance 19
Key Stats 20
Geographical Segment: Europe 20
Target Markets 20
Performance 20
Geographical Segment: Japan 20
Performance 20
Geographical Segment: Northeast Asia 20
Performance 20
Overview 20
Geographical Segment: Southeast Asia 20
Target Markets 20
Performance 20
Geographical Segment: The Americas 20
Target Markets 20
Performance 21
Inabata & Co Ltd – Corporate Strategy 22
Inabata & Co Ltd – SWOT Analysis 23
SWOT Analysis – Overview 23
Inabata & Co Ltd – Strengths 23
Inabata & Co Ltd – Weaknesses 24
Inabata & Co Ltd – Opportunities 25
Inabata & Co Ltd – Threats 26
Inabata & Co Ltd – Key Competitors 27
Section 3 – Company Financial Ratios 28
Financial Ratios – Capital Market Ratios 28
Financial Ratios – Annual Ratios 29
Performance Chart 32
Financial Performance 32
Financial Ratios – Interim Ratios 33
Financial Ratios – Ratio Charts 34
Section 4 – Appendix 35
Methodology 35
Ratio Definitions 35
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Inabata & Co Ltd, Key Facts 6
Inabata & Co Ltd, Key Employees 7
Inabata & Co Ltd, Major Products and Services 9
Inabata & Co Ltd, History 10
Inabata & Co Ltd, Other Locations 14
Inabata & Co Ltd, Subsidiaries 14
Inabata & Co Ltd, Key Competitors 27
Inabata & Co Ltd, Ratios based on current share price 28
Inabata & Co Ltd, Annual Ratios 29
Inabata & Co Ltd, Annual Ratios (Cont...1) 30
Inabata & Co Ltd, Annual Ratios (Cont...2) 31
Inabata & Co Ltd, Interim Ratios 33
Currency Codes 35
Capital Market Ratios 35
Equity Ratios 36
Profitability Ratios 36
Cost Ratios 37
Liquidity Ratios 37
Leverage Ratios 38
Efficiency Ratios 38

List of Figures
Inabata & Co Ltd, Performance Chart (2014 - 2018) 32
Inabata & Co Ltd, Ratio Charts 34

★海外企業調査レポート[Inabata & Co Ltd (8098):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Serina Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Serina Therapeutics Inc (Serina Therapeutics) is a drug company that develops therapeutics for cancer, inflammation, pain, and metabolic disorders. The company’s pipeline product includes SER-214, SER-226, SER-228, SER-232, and other proprietary drugs. It uses proprietary technology, polyoxa …
  • EnerDel Inc:企業の戦略的SWOT分析
    EnerDel Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Henry Schein Inc (HSIC)-製薬・医療分野:企業M&A・提携分析
    Summary Henry Schein, Inc. (Henry Schein) is a distributor of healthcare products and services. Its product and service portfolio consists of dental products, medical products, animal health products, software and technology and other value-added services. It offers generic and branded pharmaceutica …
  • Breakthru Beverage Group, LLC:企業の戦略・SWOT・財務分析
    Breakthru Beverage Group, LLC - Strategy, SWOT and Corporate Finance Report Summary Breakthru Beverage Group, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • HSS Engineers Berhad (HSSEB):企業の財務・戦略的SWOT分析
    HSS Engineers Berhad (HSSEB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Sunstar Holding AG:企業の戦略・SWOT・財務分析
    Sunstar Holding AG - Strategy, SWOT and Corporate Finance Report Summary Sunstar Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Sonesta International Hotels Corporation:企業の戦略・SWOT・財務情報
    Sonesta International Hotels Corporation - Strategy, SWOT and Corporate Finance Report Summary Sonesta International Hotels Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Sevion Therapeutics Inc (SVON)-製薬・医療分野:企業M&A・提携分析
    Summary Sevion Therapeutics Inc (Sevion), formerly Senesco Technologies, Inc. is a pharmaceutical company that discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company has developed protein nanocage system that allows delivery of nucleic …
  • NetEnt AB (NET B):企業の財務・戦略的SWOT分析
    Summary NetEnt AB (NetEnt), formerly Net Entertainment NE AB, is a gaming solution provider. The company offers netent live, pooled jackpots, branded games, casinomodule, back office, touch, live casino and extend. It provides services such as business intelligence, regulated markets, iGaming media …
  • Neptune Orient Lines Limited:企業の戦略・SWOT・財務情報
    Neptune Orient Lines Limited - Strategy, SWOT and Corporate Finance Report Summary Neptune Orient Lines Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • iBio Inc (IBIO):企業の財務・戦略的SWOT分析
    Summary iBio Inc (iBio) is a biotechnology company that develops and manufactures plant made pharmaceutical products. The company provides products such as biotherapeutics and vaccines. It has its applications in ibiolaunch platform, which is a transformative technology for the production of monoclo …
  • Antibe Therapeutics Inc (ATE)-製薬・医療分野:企業M&A・提携分析
    Summary Antibe Therapeutics Inc (Antibe) is a biotechnology company that designs and develops drug candidates for chronic pain and inflammation; and regenerative medicine. The company discovers and commercialize novel drugs, biologics and medical devices. It offers lead compound ATB-346, a naproxen …
  • Exiqon AS:医療機器:M&Aディール及び事業提携情報
    Summary Exiqon AS (Exiqon), a subsidiary of Qiagen NV, is a medical device company that develops, manufactures and markets molecular diagnostic test products. The company provides product categories such as microRNA research, incRNA research, mRNA research, DNA research, custom oligos and other reag …
  • Baylor Scott & White Health-製薬・医療分野:企業M&A・提携分析
    Summary Baylor Scott & White Health (Baylor Scott & White) is a non-profit organization that provides medical care services. The organization provides medical education, medical services and conducts medical research. It offers medical services in the area of emergency care, cancer care, behavioral …
  • Lantheus Medical Imaging Inc-医療機器分野:企業M&A・提携分析
    Summary Lantheus Medical Imaging Inc (Lantheus Medical), a subsidiary of Lantheus Holdings, Inc., develops, manufactures, and commercializes diagnostic imaging agents and products for the diagnosis of conditions that affect heart, brain, lungs and other organs using echocardiography and nuclear imag …
  • EMCOR Group, Inc.:企業の戦略・SWOT・財務情報
    EMCOR Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary EMCOR Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Intellicheck, Inc. (IDN):企業の財務・戦略的SWOT分析
    Intellicheck, Inc. (IDN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Aspen Aerogels Inc (ASPN):企業の財務・戦略的SWOT分析
    Summary Aspen Aerogels Inc (Aspen Aerogels) is an energy technology company that manufactures, designs, and develops thermal management solutions. The company’s products include Cryozel Z, Pyrogel XT-E, Cryogel x201, Pyrogel XTF, Spaceloft, and Spaceloft Subsea. Aspen Aerogels insulation is also use …
  • The Mosaic Company:企業の戦略・SWOT・財務分析
    The Mosaic Company - Strategy, SWOT and Corporate Finance Report Summary The Mosaic Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • RhythmOne plc:企業のM&A・事業提携・投資動向
    RhythmOne plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RhythmOne plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆